Option auswählen

Abcalis GmbH

Inhoffenstr. 7, 38124 Braunschweig

Kontaktdaten an Aussteller übermitteln

Übermitteln Sie dem Aussteller Ihre Kontaktdaten. Optional können Sie eine persönliche Nachricht ergänzen.

Bitte einloggen

Sie müssen angemeldet sein, um die Kontaktanfrage zu senden.

Ein Fehler ist aufgetreten

Bitte überprüfen Sie Ihre Internetverbindung oder versuchen Sie es zu einem späteren Zeitpunkt noch einmal.

Nachricht erfolgreich gesendet

Ihre Nachricht an den Aussteller wurde erfolgreich gesendet.


Dr. Laila Al-Halabi-Frenzel


Pascal Milfeit


+49 151 26517262


Bitte einloggen

Sie müssen angemeldet sein, um das Matchmaking nutzen zu können.

Bitte für Matchmaking einloggen

Für die Nutzung des Networking Services ist eine Registrierung und eine separate Anmeldung für das Matchmaking notwendig. Bitte melden Sie sich zunächst für das Matchmaking an.

Es kann losgehen!

Willkommen zum Matchmaking. Möchten Sie mit in Kontakt treten?

Unser Angebot


  • 03  Diagnostika
  • 03.02  Immunochemie / Immunologie
  • 03.02.01  Immun-Assay-Systeme
  • 03  Diagnostika
  • 03.02  Immunochemie / Immunologie
  • 03.02.02  Diagnose-Schnelltests


Unsere Produkte

Produktkategorie: Immun-Assay-Systeme

Abcalis© Multiclonals

MULTICLONAL recombinant antibodies combine the best features of polyclonal antisera
and monoclonal antibodies while eliminating their disadvantages. By detecting more
than one epitope of the antigen, MULTICLONALS provide the sensitivity and reliability of
polyclonals, but unlike polyclonals, they do not contain any additional unknown IgG.
Accurately selected antibodies are combined in the mix, which are always defined by
their sequence. As a result, MULTICLONALS provide unlimited reproducibility and
minimized unwanted side reactivities, establishing a new quality standard for secondary
antibodies. The generation and production of MULTICLONALS is entirely animal free.

Mehr Weniger

Produktkategorie: Diagnose-Schnelltests

Abcalis© SARS-CoV-2 Antibodies

Abcalis® anti-SARS-CoV-2 antibodies are high quality recombinant monoclonal primary antibodies 
Abcalis’ product portfolio now also features anti-SARS-CoV-2 recombinant (sequence defined) monoclonal antibodies. Currently, we are offering a variety of different clones with specificities to the S1-, S1+S2-, RBD- as well as N-protein and can work with them in different projects for different applications. 
The solutions from and with Abcalis are qualified to meet regulatory standards and criteria even in the long term, as is the standard with all Abcalis products, since they are all completely sequence defined, implying their unlimited long-term availability and always identical test results. This allows for a much lower unspecific binding reactivity in many assays compared to animal based products.
Simply contact us with your specific needs or request for your setup and we will gladly explore possibilities together!

Mehr Weniger

Produktkategorie: Immun-Assay-Systeme

Abcalis© recombinant antibody services

Along with our product portfolio, we also offer a variety of services around antibody development, immunoassay development, as well as antibody engineering. Through our knowledge and technology, we remain highly flexible for individual needs and specific scenarios of our customers.

Mehr Weniger

Über uns


For a more sustainable future.
And higher quality of your results.

Abcalis is specialized in a new class of recombinant antibodies for diagnostics.
Our antibodies are carefully selected via phage-display and are produced entirely in-vitro, without animal use. They are flexibly applicable to our customers' individual needs and scenarios, and are reproducible forever. We do not use hybridomas.

Our founders all share the same vision: a world of next generation diagnostic antibodies that share a revolutionary level of quality and are completely animal-free.

It is our mission and aspiration every single day to achieve this goal, both for a sustainable future and medical safety of this and every future generation to come.


Geschäftsfelder Diagnostika